Bioventix Past Earnings Performance
Past criteria checks 3/6
Bioventix has been growing earnings at an average annual rate of 6.8%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 7.8% per year. Bioventix's return on equity is 67.5%, and it has net margins of 59.5%.
Key information
6.8%
Earnings growth rate
6.5%
EPS growth rate
| Biotechs Industry Growth | -14.6% |
| Revenue growth rate | 7.8% |
| Return on equity | 67.5% |
| Net Margin | 59.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bioventix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 14 | 8 | 2 | 0 |
| 31 Mar 24 | 14 | 8 | 2 | 0 |
| 31 Dec 23 | 14 | 9 | 2 | 0 |
| 30 Sep 23 | 13 | 9 | 2 | 0 |
| 30 Jun 23 | 13 | 8 | 2 | 0 |
| 31 Mar 23 | 13 | 8 | 2 | 0 |
| 31 Dec 22 | 13 | 8 | 2 | 0 |
| 30 Sep 22 | 12 | 8 | 2 | 0 |
| 30 Jun 22 | 12 | 8 | 2 | 0 |
| 31 Mar 22 | 11 | 7 | 2 | 0 |
| 31 Dec 21 | 10 | 7 | 2 | 0 |
| 30 Sep 21 | 11 | 7 | 2 | 0 |
| 30 Jun 21 | 11 | 7 | 2 | 0 |
| 31 Mar 21 | 11 | 7 | 2 | 0 |
| 31 Dec 20 | 10 | 7 | 2 | 0 |
| 30 Sep 20 | 10 | 7 | 2 | 0 |
| 30 Jun 20 | 10 | 7 | 2 | 0 |
| 31 Mar 20 | 10 | 7 | 1 | 0 |
| 31 Dec 19 | 10 | 7 | 1 | 0 |
| 30 Sep 19 | 10 | 6 | 1 | 0 |
| 30 Jun 19 | 9 | 6 | 1 | 0 |
| 31 Mar 19 | 9 | 6 | 1 | 0 |
| 31 Dec 18 | 9 | 6 | 1 | 0 |
| 30 Sep 18 | 9 | 6 | 1 | 0 |
| 30 Jun 18 | 9 | 6 | 1 | 0 |
| 31 Mar 18 | 9 | 6 | 1 | 0 |
| 31 Dec 17 | 8 | 6 | 1 | 0 |
| 30 Sep 17 | 8 | 5 | 1 | 0 |
| 30 Jun 17 | 7 | 5 | 1 | 0 |
| 31 Mar 17 | 7 | 5 | 1 | 0 |
| 31 Dec 16 | 6 | 4 | 1 | 0 |
| 30 Sep 16 | 6 | 4 | 1 | 0 |
| 30 Jun 16 | 6 | 3 | 1 | 0 |
| 31 Mar 16 | 5 | 3 | 1 | 0 |
| 31 Dec 15 | 5 | 3 | 1 | 0 |
| 30 Sep 15 | 5 | 3 | 1 | 0 |
| 30 Jun 15 | 4 | 3 | 1 | 0 |
| 31 Mar 15 | 4 | 2 | 1 | 0 |
| 31 Dec 14 | 4 | 2 | 1 | 0 |
| 30 Sep 14 | 4 | 2 | 1 | 0 |
| 30 Jun 14 | 4 | 2 | 1 | 0 |
| 31 Mar 14 | 3 | 2 | 1 | 0 |
| 31 Dec 13 | 3 | 2 | 1 | 0 |
Quality Earnings: 51B has high quality earnings.
Growing Profit Margin: 51B's current net profit margins (59.5%) are lower than last year (65.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 51B's earnings have grown by 6.8% per year over the past 5 years.
Accelerating Growth: 51B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 51B had negative earnings growth (-3.3%) over the past year, making it difficult to compare to the Biotechs industry average (-21.2%).
Return on Equity
High ROE: 51B's Return on Equity (67.5%) is considered outstanding.